JULIA CLARK: Open Payments
NPI 1093180473 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 9 payments from 7 companies in 2025. Trend: 2023 $134 · 2024 $110 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $49 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $42 |
| Grifols USA, LLC | 1 | $39 |
| Amgen Inc. | 1 | $24 |
| MOTIVA USA, LLC | 1 | $24 |
| GENZYME CORPORATION | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: NEFFY, TEZSPIRE, Xembify, BOTOX, Motiva Implant Matrix, QULIPTA.
Industry payments across GA — which companies pay providers there.
